These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10467200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Van de Werf F, Aylward PE, Topol EJ.
    Circulation; 1995 Nov 15; 92(10):2811-8. PubMed ID: 7586246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
    Singh N, Mironov D, Armstrong PW, Ross AM, Langer A.
    Circulation; 1996 Apr 01; 93(7):1388-95. PubMed ID: 8641028
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ.
    Stroke; 1998 Mar 01; 29(3):563-9. PubMed ID: 9506593
    [Abstract] [Full Text] [Related]

  • 8. An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
    Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, Selker HP.
    Am J Med; 2002 Aug 01; 113(2):104-11. PubMed ID: 12133748
    [Abstract] [Full Text] [Related]

  • 9. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
    White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ.
    Circulation; 1996 Oct 15; 94(8):1826-33. PubMed ID: 8873656
    [Abstract] [Full Text] [Related]

  • 10. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ, Topol EJ, Holmes DR, White HD, Rutsch WR, Vahanian A, Simoons ML, Morris D, Betriu A, Califf RM.
    Circulation; 1995 Apr 01; 91(7):1923-8. PubMed ID: 7895348
    [Abstract] [Full Text] [Related]

  • 11. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
    Barbash GI, Birnbaum Y, Bogaerts K, Hudson M, Lesaffre E, Fu Y, Goodman S, Houbracken K, Munsters K, Granger CB, Pieper K, Califf RM, Topol EJ, Van De Werf F.
    Circulation; 2001 Feb 20; 103(7):954-60. PubMed ID: 11181469
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators.
    N Engl J Med; 1993 Sep 02; 329(10):673-82. PubMed ID: 8204123
    [Abstract] [Full Text] [Related]

  • 14. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
    Hudson MP, Granger CB, Topol EJ, Pieper KS, Armstrong PW, Barbash GI, Guerci AD, Vahanian A, Califf RM, Ohman EM.
    Circulation; 2001 Sep 11; 104(11):1229-35. PubMed ID: 11551872
    [Abstract] [Full Text] [Related]

  • 15. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM.
    J Am Coll Cardiol; 1997 Dec 11; 30(7):1606-10. PubMed ID: 9385883
    [Abstract] [Full Text] [Related]

  • 16. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
    Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ.
    Ann Intern Med; 1998 Oct 15; 129(8):597-604. PubMed ID: 9786806
    [Abstract] [Full Text] [Related]

  • 17. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction.
    Kalish SC, Gurwitz JH, Krumholz HM, Avorn J.
    J Gen Intern Med; 1995 Jun 15; 10(6):321-30. PubMed ID: 7562123
    [Abstract] [Full Text] [Related]

  • 18. Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction.
    Al Khuwaitir TS, Wani BA, Dawood HA, Khan MA.
    Saudi Med J; 2005 Jan 15; 26(1):130-2. PubMed ID: 15756370
    [Abstract] [Full Text] [Related]

  • 19. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD.
    Am J Cardiol; 1998 Oct 22; 82(8B):57P-62P. PubMed ID: 9809893
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications.
    Kikkert WJ, van Geloven N, van der Laan MH, Vis MM, Baan J, Koch KT, Peters RJ, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP.
    J Am Coll Cardiol; 2014 May 13; 63(18):1866-75. PubMed ID: 24657697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.